BiotechTube
Home/Immatics Biotechnologies/Carsten Reinhardt, M.D., Ph.D.
CR

Carsten Reinhardt, M.D., Ph.D.

Chief Development Officer

Immatics Biotechnologies

Roles

Chief Development OfficeratImmatics Biotechnologies
Chief Development OfficeratImmatics

Therapeutic Areas

OncologySolid Tumors

Immatics Biotechnologies Pipeline

DrugIndicationPhase
IMA203PRAME-positive solid tumorsPhase 1/2
IMA203CD8PRAME-positive solid tumorsPhase 1/2
IMA402PRAME-positive solid tumorsPhase 1/2
IMA204Undisclosed solid tumorsPhase 1

Leadership Team at Immatics Biotechnologies

HS
Harpreet Singh, Ph.D.
Chief Executive Officer
CB
Cedrik Britten, M.D.
Chief Medical Officer
SW
Steffen Walter, Ph.D.
Chief Operating Officer
TW
Toni Weinschenk, Ph.D.
Chief Innovation Officer
VR
Venkat Ramanan, Ph.D.
Chief Financial Officer
RK
Rainer Kramer, Ph.D.
Chief Business Officer & Site Head Munich
ES
Edward Sturchio, J.D.
General Counsel
PC
Peter Chambré
Chairman of the Board of Directors
HL
Heather L. Mason
Vice Chair of the Board of Directors
View full Immatics Biotechnologies profile